Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06565442 · ClinicalTrials.gov registry record
Feasibility of Using NeuraSignal Transcranial Doppler Robot
A clinical trial, sponsored by University of Alabama at Birmingham.
- Not yet
- Registry status
- 20
- Enrollment target
NCT06565442 is a clinical trial that has not yet begun recruiting, run by University of Alabama at Birmingham. The registered enrollment target is 20 participants.
The verdict
NCT06565442 has not yet begun recruiting, sponsored by University of Alabama at Birmingham.
- NOT YET RECRUITING
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
Interventions
- DEVICE NeuraSignal transcranial doppler robot
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-15 |
| Est. Completion | 2027-12-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06565442
The ClinicalTrials.gov registry entry for NCT06565442 describes a study currently listed as not yet recruiting, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which NeuraSignal transcranial doppler robot is the first listed.
NCT06565442 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06565442 about?
NCT06565442 is a clinical study titled "Feasibility of Using NeuraSignal Transcranial Doppler Robot". The purpose of this study is to determine the feasibility of using the NeuraSignal transcranial doppler robot in a neuro ICU setting to measure cerebral blood flow correlated with arterial blood pressure to generate individualized cerebral autoregulatory curves
What is the current status of trial NCT06565442?
This trial is currently not yet recruiting. The enrollment target is 20 participants. The study started on 2026-06-15. Estimated completion is 2027-12-15.
What interventions are being tested in trial NCT06565442?
The interventions under investigation include: NeuraSignal transcranial doppler robot (DEVICE).
Who is sponsoring clinical trial NCT06565442?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.